Inventor · disambiguated record
Thumkunta Jagadeeswar Reddy
Also filed as: REDDY THUMKUNTA JAGADEESWAR
18 granted patents·5 pending applications·213 citations·filing 2002–2024
92Inventor score
Files withVERTEX PHARMA12VIROCHEM PHARMA INC4CHAN CHUN KONG LAVAL2VERTEX PHARMACEUTICALS CANADA INC1VIRO CHEM PHARMA INC1
Top patents by PatentIndex Score
23 records- 0194US6881741B2Compounds and methods for the treatment or prevention of Flavivirus infectionsVIROCHEM PHARMA INC·Filed 2002·Granted Apr 19, 2005·107 cites·174 claims
- 0290US7402608B2Compounds and methods for the treatment or prevention of Flavivirus infectionsVIROCHEM PHARMA INC·Filed 2003·Granted Jul 22, 2008·37 cites·40 claims
- 0390US6936629B2Compounds and methods for the treatment or prevention of flavivirus infectionsVIROCHEM PHARMA INC·Filed 2002·Granted Aug 30, 2005·51 cites·78 claims
- 0482US7985769B2Compounds and methods for the treatment or prevention of Flavivirus infectionsVERTEX PHARMA·Filed 2005·Granted Jul 26, 2011·6 cites·61 claims
- 0580US8357718B2Compounds and methods for the treatment or prevention of flavivirus infectionsVERTEX PHARMACEUTICALS CANADA INC·Filed 2008·Granted Jan 22, 2013·2 cites·5 claims
- 0674US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0773US11634447B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2020·Granted Apr 25, 2023·0 cites·20 claims
- 0871US9598454B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Granted Mar 21, 2017·1 cites·17 claims
- 0969US10669298B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2018·Granted Jun 2, 2020·0 cites·20 claims
- 1067US10913761B22,7-dibromospiro[fluorene-9,4′-piperidine] compoundsVERTEX PHARMA·Filed 2020·Granted Feb 9, 2021·0 cites·12 claims
- 1167US7288548B2Spiro compounds and methods for the modulation of chemokine receptor activityVIROCHEM PHARMA INC·Filed 2004·Granted Oct 30, 2007·4 cites·40 claims
- 1265US9890176B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 1364US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 1462US7351713B2Spirohydantoin compounds and methods for the modulation of chemokine receptor activityVIRO CHEM PHARMA INC·Filed 2004·Granted Apr 1, 2008·4 cites·39 claims
- 1561US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1656US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 1756US9963478B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted May 8, 2018·0 cites·32 claims
- 1853US2013123242A1Compounds and methods for the treatment or prevention of flavivirus infectionsCHAN CHUN KONG LAVAL·Filed 2012·Application pending·0 cites
- 1952US8329924B2Compounds and methods for the treatment or prevention of Flavivirus infectionsCHAN CHUN KONG LAVAL·Filed 2011·Granted Dec 11, 2012·0 cites·13 claims
- 2044US2005075326A1Spiro compounds and methods for the modulation of chemokine receptor activityFiled 2004·Application pending·0 cites
- 2141US10787443B2RAF-degrading conjugate compoundsZAMBONI CHEM SOLUTIONS INC·Filed 2018·Granted Sep 29, 2020·0 cites·27 claims
- 2241US2004192707A1Compounds and methods for the treatment or prevention of Flavivirus infectionsFiled 2003·Application pending·0 cites
- 2337US10407414B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted Sep 10, 2019·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →